American Research & Management Company’s Pacira BioSciences PCRX Stock Holding History

American Research & Management Company’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$6K	Hold	104	–	–	﹤0.01%	315
2022 Q2	$6K	Hold	104	–	–	﹤0.01%	318
2022 Q1	$8K	Hold	104	–	–	﹤0.01%	317
2021 Q4	$6K	Hold	104	–	–	﹤0.01%	333
2021 Q3	$6K	Hold	104	–	–	﹤0.01%	330
2021 Q2	$6K	Hold	104	–	–	﹤0.01%	339
2021 Q1	$7K	Hold	104	–	–	﹤0.01%	313
2020 Q4	$6K	Hold	104	–	–	﹤0.01%	319
2020 Q3	$6K	Hold	104	–	–	﹤0.01%	286
2020 Q2	$5K	Hold	104	–	–	﹤0.01%	297
2020 Q1	$3K	Buy	+104	New	+$4.32K	﹤0.01%	298

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

American Research & Management Company's PCRX Position: Q3 2022 in Review

American Research & Management Company held its Pacira BioSciences (PCRX) position steady in Q3 2022 at 104 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #315.

American Research & Management Company first reported a position in PCRX in Q1 2020 and has held it in 11 quarters since. The position peaked at $8K in Q1 2022. 272 funds tracked by Wall St. Rank hold PCRX as of Q3 2022.

American Research & Management Company held 104 shares of Pacira BioSciences worth $6K as of Q3 2022.
American Research & Management Company left its Pacira BioSciences share count unchanged in Q3 2022.
Pacira BioSciences made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #315 holding.
American Research & Management Company first reported a position in Pacira BioSciences in Q1 2020 and has held it in 11 quarters since.
American Research & Management Company's Pacira BioSciences position peaked at $8K in Q1 2022.
272 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.